Received: 5 February 2021
Accepted: 30 March 2021
First Online: 26 May 2021
: This study was performed in accordance with the Declaration of Helsinki and was approved by Ethics Subcommittee for the Life and Health Sciences of University of Minho, Portugal, and by the Ethics Committee of the Hospital of Braga, Portugal. All subjects were provided with written informed consent following description of the study goals and procedures.
: Not applicable.
: P Morgado has received in the past 3 years grants, CME-related honoraria, or consulting fees from Angelini, AstraZeneca, Bial Foundation, Biogen, DGS-Portugal, FCT, Janssen-Cilag, Gulbenkian Foundation, Lundbeck, Springer Healthcare, Tecnimede and 2CA-Braga. C Raposo-Lima, IM Pereira and F Marques declare no conflict of interests.